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Liver transplantation is transformative for patients with an extensive range of liver diseases. 
Early outcomes are excellent and extended survival beyond 20 years is now a realistic 
expectation for many patients receiving liver grafts. The success of liver transplantation is 
counter-balanced by the limitations imposed by the number of organs available from 
deceased donors and this has, appropriately, created an ethos that maximum benefit should 
be derived by society from the organs generously donated. Individual patients do not have 
an entitlement to liver transplantation and those fortunate enough to be selected to receive 
an organ are expected to conform to restrictive policy and regulation designed to maximise 
the quantum of that benefit. The boundaries that have evolved are clear, but not necessarily 
fair, and many more patients are excluded from access to an intervention from which they 
would benefit to a substantial degree.  
Donation of liver tissue by a volunteer changes the dynamic of access to transplantation but 
not necessarily the associated restrictions. The Vancouver Forum report stated that ‘the 
indications for live donor liver transplantation should be the same as those for deceased 
donor transplantation’(1).  Maintaining consistent discipline across the entire practice of liver 
transplantation has merit as it supports the principle that the degree of risk to the donor is 
justified by the high expectation of benefit to the recipient. However, the clarity of that quote 
is challenged by another statement from the same report that stated ‘survival of a live donor 
should approximate to the expected outcome for a recipient with the same aetiology 
undergoing a deceased donor transplant’(1). This loop hole allows a case to develop that is 
permissive of minor relaxations of policy and this is precisely what is argued by Lieber et al 
in this month’s edition of the Journal of Hepatology (2).  
The clinical vignettes used to develop the case are two real stories with some modifications 
designed to enhance clarity and insightfulness. One of these uses the easily recognisable 
scenario of hepatocellular carcinoma that is marginally excluded from transplantation on the 
basis of tumour bulk. The Vancouver Forum report considered hepatocellular to be 
controversial but confirmed that the indications for transplantation should be the same for 
deceased and living donors. An international consensus in 2010 addressed the issue and, 
while experts were divided, the jury took a conditional stance which was permissive but 
stipulated that clarity of position, good communication and rigorous surveillance were 
essential requirements if offering liver transplantation to patients beyond standard criteria 
(3). The unique features of living donation could make it ethical if the 5-year survival rate 
was greater than 50%, which is the empiric but widely utilised metric by which outcomes are 
judged as acceptable. Five-year survival rates well above this threshold have already been 
documented with modest expansions of the Milan criteria (4,5).  
Unfortunately, Lieber and colleagues used the same threshold as the starting point from 
which to allow minor change, arguing that it could be reduced from 50% to 40% 5-year 
survival. Firstly, this degree of change does not seem to be consistent with the spirit of a 
minor adjustment. Secondly, and more importantly, the tumour bulk profiles associated with 
these outcomes as predicted by the ‘metroticket’ would allow transplantation in patients with 
more than 10 nodules or with a nodule with a maximum diameter of 10cm (6). This 
represents a radical shift in the practice of transplantation for hepatocellular carcinoma and 
is unlikely to gain much support, even though the results are perfectly acceptable by general 
oncological principles. However, this does not discredit the argument entirely as the use of 
75% and 70% thresholds would have reflected a liberalisation from 2 nodules up to 4 cm in 
  
diameter to 4 nodules with a maximum diameter of 6 cm. The degree of change is much 
more compatible with the starting premise of marginal change.  
With this change in perspective, the argument put by Lieber becomes more compelling at an 
individual patient level. Advocating clinicians would point to an excellent outcome in the 
absence of any disadvantage other than to the donor who must be accepting of a 0.4% risk 
of death and a 35% morbidity rate (1). Why then should the case not be approved?  One 
reason is that the status quo is transparent and equitable and thus a comfortable benchmark 
in the decision-making paradigm. Change brings uncertainty and in the case of this example 
there may be a degree of concern that this adjustment is the thin edge of the proverbial 
wedge that could gather momentum and drive radical departure from current practice. A 
potential compromise would be to agree a limited and defined modicum of change without 
setting a precedent for further modifications based on the same rationale.      
The other case deals with behavioural and societal issues and is a much more difficult 
argument to engage objectively. I suspect many readers would forgive an 18-year old patient 
a lot and factor-in the potential to mature and function within the bounds of acceptable 
behaviour. The largesse of donation and the process of liver transplantation could be both 
the catalyst and sustaining drive for such change. On the other hand, it would be considered 
irresponsible to put a donor at risk if the recipient was exhibiting culpable recklessness and 
the decision of the team who are familiar with the details of the case warrants respect.  
Alcohol-related liver disease was not addressed by Lieber et al but it is another example of 
behaviour influencing candidacy for liver transplantation. A commitment to abstaining from 
alcohol is a requirement for deceased donor transplantation and in many programmes the 
ability to do so needs to be demonstrated for a period of time before the candidate is 
activated on the wait list. However, this requirement is open to the criticism of not being 
evidence-based and empiric in its application. It is therefore a scenario where a difference in 
behaviour prior to deceased and living donor transplantation could emerge. The degree of 
drift from existing policy that would be considered minor and reasonable would be much 
more difficult to define than in the case of hepatocellular carcinoma. The possibility that 
access to living donor liver transplantation becomes easier for non-reformed alcohol abusers 
because of fame, wealth or power of persuasion should be resisted.   
The principle that the indications for living and deceased donor transplantation must be 
identical is not sacrosanct. Change that maintains equivalence in outcome should be 
considered and the lessons learned can then be applied to the population awaiting 
deceased donor transplantation. The challenge is to regulate and monitor the change whilst 
maintaining a discipline that promotes the greater good.  
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